ALX ONCOLOGY HOLDINGS INC (ALXO) Free cash flow 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$84.4MFY2025 · since FY2018: -$13.8M → -$84.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.4M | +31.1% |
| FY2024 | -$122.4M | +7.0% |
| FY2023 | -$131.6M | -45.2% |
| FY2022 | -$90.7M | -31.8% |
| FY2021 | -$68.8M | -79.5% |
| FY2020 | -$38.3M | -162.4% |
| FY2019 | -$14.6M | -5.5% |
| FY2018 | -$13.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice